Optimum Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$423K Buy
3,345
+84
+3% +$10.6K 0.18% 106
2025
Q1
$417K Buy
3,261
+19
+0.6% +$2.43K 0.2% 105
2024
Q4
$429K Buy
3,242
+56
+2% +$7.4K 0.19% 111
2024
Q3
$464K Buy
3,186
+162
+5% +$23.6K 0.2% 106
2024
Q2
$415K Buy
3,024
+85
+3% +$11.7K 0.19% 114
2024
Q1
$403K Sell
2,939
-129
-4% -$17.7K 0.19% 113
2023
Q4
$417K Sell
3,068
-370
-11% -$50.3K 0.21% 105
2023
Q3
$420K Buy
3,438
+44
+1% +$5.38K 0.22% 111
2023
Q2
$431K Sell
3,394
-62
-2% -$7.87K 0.21% 114
2023
Q1
$446K Buy
3,456
+94
+3% +$12.1K 0.23% 106
2022
Q4
$441K Sell
3,362
-516
-13% -$67.8K 0.24% 102
2022
Q3
$454K Sell
3,878
-251
-6% -$29.4K 0.24% 96
2022
Q2
$486K Buy
4,129
+127
+3% +$14.9K 0.24% 97
2022
Q1
$521K Buy
4,002
+17
+0.4% +$2.21K 0.22% 105
2021
Q4
$608K Buy
3,985
+30
+0.8% +$4.58K 0.24% 94
2021
Q3
$639K Sell
3,955
-339
-8% -$54.8K 0.27% 88
2021
Q2
$703K Sell
4,294
-244
-5% -$39.9K 0.22% 99
2021
Q1
$683K Buy
4,538
+247
+6% +$37.2K 0.2% 111
2020
Q4
$650K Buy
4,291
+73
+2% +$11.1K 0.2% 112
2020
Q3
$571K Buy
4,218
+39
+0.9% +$5.28K 0.19% 117
2020
Q2
$571K Buy
4,179
+122
+3% +$16.7K 0.2% 117
2020
Q1
$437K Buy
4,057
+203
+5% +$21.9K 0.18% 135
2019
Q4
$464K Sell
3,854
-10
-0.3% -$1.2K 0.14% 169
2019
Q3
$384K Buy
3,864
+70
+2% +$6.96K 0.12% 180
2019
Q2
$414K Buy
3,794
+184
+5% +$20.1K 0.13% 165
2019
Q1
$404K Buy
3,610
+79
+2% +$8.84K 0.13% 170
2018
Q4
$340K Buy
3,531
+63
+2% +$6.07K 0.12% 177
2018
Q3
$423K Buy
3,468
+194
+6% +$23.7K 0.12% 176
2018
Q2
$360K Sell
3,274
-227
-6% -$25K 0.1% 201
2018
Q1
$374K Buy
3,501
+104
+3% +$11.1K 0.11% 191
2017
Q4
$363K Buy
+3,397
New +$363K 0.12% 199
2015
Q1
$24K Hold
210
0.01% 650
2014
Q4
$21K Buy
+210
New +$21K 0.01% 698